Going Viral

Earning CPD by listening to Healthed podcasts is simple. Each episode is eligible for Educational Activities CPD.

Filter results

0.5 EA, 0.5 RP

Transitioning our patients to Novavax and protein-based vaccines and away from mRNA. Monkeypox should be taken seriously... especially for high-risk patients

0.5 EA, 0.5 RP

Some ‘basic’ influenza epidemiology, what happened in 2021 and what to expect in 2022, what's new with cell culture influenza vaccines and high dose influenza vaccines, and importance of vaccination rates

0.5 EA, 0.5 RP

Current burden and variants, long COVID and vaccines, and COVID vaccine boosters - effectiveness and safety and the need for a 4th dose

0.5 EA, 0.5 RP

New advice on when to vaccinate after COVID infection

0.5 EA, 0.5 RP

Should GPs have a fourth booster? The Ba4 and Ba5 variants, more information on the antivirals, long COVID is an emerging public health issue.

0.5 EA, 0.5 RP

A look at our local and national infection rates- what does the medium to long term future look like?

0.5 EA, 0.5 RP

Ba2, Deltacron, Omicron and other variants- the winter booster - for which patients? An update on the other vaccines and the COVID antivirals.

0.5 EA, 0.5 RP

Overseas travel and COVID - booster before travelling? What’s the evidence? The more transmissible OMICRON subvariant... is there any cause for concern here?

0.5 EA, 0.5 RP

Olfactory disturbances with COVID19 is evidence of brain involvement- consider a neuropsychological assessment for patients complaining of fatigue, poor attention span, slower processing speed.

0.5 EA, 0.5 RP

A clinical overview of Novavax, is a fourth booster imminent for Australia? Post-COVID cardiovascular risk.

0.5 EA, 0.5 RP

COVID is not the only preventable infectious disease - influenza, pertussis, and pneumonia are also very important

0.5 EA, 0.5 RP

Vaccine inequity is not the main reason the Congo is not immunised against COVID-19

Transitioning our patients to Novavax and protein-based vaccines and away from mRNA. Monkeypox should be taken seriously... especially for high-risk patients

Some ‘basic’ influenza epidemiology, what happened in 2021 and what to expect in 2022, what's new with cell culture influenza vaccines and high dose influenza vaccines, and importance of vaccination rates

Current burden and variants, long COVID and vaccines, and COVID vaccine boosters - effectiveness and safety and the need for a 4th dose

New advice on when to vaccinate after COVID infection

Should GPs have a fourth booster? The Ba4 and Ba5 variants, more information on the antivirals, long COVID is an emerging public health issue.

A look at our local and national infection rates- what does the medium to long term future look like?

Ba2, Deltacron, Omicron and other variants- the winter booster - for which patients? An update on the other vaccines and the COVID antivirals.

Overseas travel and COVID - booster before travelling? What’s the evidence? The more transmissible OMICRON subvariant... is there any cause for concern here?

Olfactory disturbances with COVID19 is evidence of brain involvement- consider a neuropsychological assessment for patients complaining of fatigue, poor attention span, slower processing speed.

A clinical overview of Novavax, is a fourth booster imminent for Australia? Post-COVID cardiovascular risk.

COVID is not the only preventable infectious disease - influenza, pertussis, and pneumonia are also very important

Vaccine inequity is not the main reason the Congo is not immunised against COVID-19

Upcoming Healthed Webcast

Tune in for "Facial rashes case studies - Practical guide to assessment and management" lecture

Tuesday 9th June, 7pm - 9pm AEST

Speaker

Dr Philip Tong

Consultant Dermatologist; Founder, DermScreen, Dermatology Junction; Visiting Medical Officer, St Vincent’s Hospital Sydney

What does it mean when a facial red rash does not respond to topical steroids and gets worse with the treatment? Dermatologist Dr Philip Tong presents a series of cases with this scenario.